Colgate Palmolive (NYSE: CL) has been producing Triclosan since 1969. It recently was banned by the FDA and the EPAs verdict is awaiting.
With a P/E of 43.88 and below average, 2.37% yield, it is vulnerable to the Class Action Lawsuits that may plague this anti-bacterial agent. It is the opinion of this author that this agent reduces the human body’s skin to fight infection or pneumococci. Additionally, this author questions whether the agent has a relationship with IOT. The Orange Gallons are being dumped on unknowing 3rd World Countries.
Consider Subscribing to my blog.